<?xml version='1.0' encoding='utf-8'?>
<document id="15180330"><sentence text="Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?" /><sentence text="The objective of the current study was to investigate whether blood-brain barrier (BBB) permeability studies in vitro could be accelerated by running several compounds together in the same experiment" /><sentence text="" /><sentence text="To address this question, we compared the transport of six compounds run separately with the results of the same compounds run together (cocktails)" /><sentence text="" /><sentence text="The study clearly demonstrated that the outcome of the experiments were totally different depending on the strategy used" /><sentence text=" Furthermore, the study highlights the importance of having the resistance to drug transport offered by filters without cells under control, as the filter membrane itself can be the rate-limiting step for some compounds; in addition, there is always a potential risk of interactions between molecules in cocktails as well as drug-drug interaction at the level of BBB transporters" /><sentence text=" In this study, the presence of several P-glycoprotein substrates in the drug cocktail was found to cause breakdown of the BBB" /><sentence text="" /><sentence text="The results demonstrate that unless a strategy that involves running several compounds in the same experiment is properly validated, the results are of little predictive value" /><sentence text="" /></document>